|
|
|
|
|
HOME >
CORPORATE INFO > CORPORATE ANNOUNCEMENTS
|
|
|
|
|
|
13-05-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxendaï¿‚ï¾® (Liraglutide) in Mexico with Medix". |
|
|
|
|
|
01-05-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding 'Intimation of receipt of Demand Orders.'. |
|
|
|
|
|
30-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding 'Receipt of Demand Orders'. |
|
|
|
|
|
25-04-2024
|
|
|
|
| BIOCON LIMITED has informed the Exchange regarding Amalgamation/ Merger |
|
|
|
|
|
25-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. |
|
|
|
|
|
23-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Investor Meeting |
|
|
|
|
|
23-04-2024
|
|
|
|
| Biocon Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
|
|
20-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding 'Notification'. |
|
|
|
|
|
17-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Investor Meeting |
|
|
|
|
|
17-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding a press release dated April 17, 2024, titled "Biocon Limited signs an exclusive licensing and supply agreement for generic Ozempic (Semaglutide) commercialization in Brazil with Biomm S.A.". |
|
|
|
|
|
15-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
|
|
12-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
|
|
12-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
|
|
|
|
|
10-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Schedule of meet |
|
|
|
|
|
10-04-2024
|
|
|
|
| BIOCON LIMITED has informed the Exchange about Board Meeting to be held on 16-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
|
|
|
|
|
09-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding 'Meeting conducted with Institutional Investors/Research Analysts'. |
|
|
|
|
|
03-04-2024
|
|
|
|
| Kiran Mazumdar Shaw has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
|
|
03-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL |
|
|
|
|
|
02-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange about Investor Meeting |
|
|
|
|
|
02-04-2024
|
|
|
|
| Biocon Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
|
|
|
|
|
|
|
|
|
|
|
|